Plain-English translation of NCT03667846 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Post Traumatic Stress Disorder research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a medication called can help people who struggle with both post-traumatic stress disorder (PTSD) and alcohol use disorder at the same time. has already been approved by the FDA for other conditions, and early evidence suggests this medication might help reduce symptoms of both PTSD and heavy drinking. The study will also look at whether your genes affect how well the medication works for you.
Many people experience both PTSD and alcohol use disorder together, and current treatments are not very effective at treating both conditions at once. Researchers believe this medication might work on the shared brain processes that cause both conditions, offering a better solution than treating them separately.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive either the medication or a placebo (inactive pill). If you receive the medication, you'll start with a low dose and gradually increase it over 8 weeks until you reach the full dose, which you'll continue for a few more weeks before gradually tapering down. Throughout the study, you'll have regular visits to check how you're doing, answer questions about your drinking and PTSD symptoms, and have blood tests to make sure the medication is safe for you. The entire study lasts about 14 weeks.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States